Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives
| Primer Autor |
Tortella, Gonzalo. R.
|
| Co-autores |
Pieretti, J. C.
Rubilar, O.
Fernandez-Baldo, M.
Benavides-Mendoza, A.
Diez, M. C.
Seabra, A. B.
|
| Título |
Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives
|
| Editorial |
TAYLOR & FRANCIS LTD
|
| Revista |
CRITICAL REVIEWS IN BIOTECHNOLOGY
|
| Lenguaje |
en
|
| Resumen |
The rapid development of nanomedicine has created a high demand for silver, copper and copper oxide nanoparticles. Due to their high reactivity and potent antimicrobial activity, silver and copper-based nanomaterials have been playing an important role in the search for new alternatives for the treatment of several issues of concern, such as pathologies caused by bacteria and viruses. Viral diseases are a significant and constant threat to public health. The most recent example is the pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this context, the object of the present review is to highlight recent progress in the biomedical uses of these metal nanoparticles for the treatment and prevention of human viral infections. We discuss the antiviral activity of AgNPs and Cu-based NPs, including their actions against SARS-CoV-2. We also discuss the toxicity, biodistribution and excretion of AgNPs and CuNPs, along with their uses in medical devices or on inert surfaces to avoid viral dissemination by fomites. The challenges and limitations of the biomedical use of these nanoparticles are presented.
|
| Tipo de Recurso |
artículo de revisión
|
| Description |
This research was funded by REDES-ANID 180003, Universidad de La Frontera DI21-1004, CONICYT/FAPESP 2018/08194-2, FAPESP ([2018/08194-2, 2018/02832-7)], CNPq ([404815/2018-9, 313117/2019-5).]. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 and ANID/FONDAP/15130015.
Esta investigación fue financiada por REDES-ANID 180003, Universidad de La Frontera DI21-1004, CONICYT/FAPESP 2018/08194-2, FAPESP ([2018/08194-2, 2018/02832-7)], CNPq ([404815/2018 -9, 313117/2019-5).]. Este estudio fue financiado en parte por la Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Código de Finanzas 001 y ANID/FONDAP/15130015.
|
| doi |
10.1080/07388551.2021.1939260
|
| Formato Recurso |
PDF
|
| Palabras Claves |
Silver nanoparticles
copper nanoparticles
(SARS-CoV-2)
viral diseases
antiviral activity
HERPES-SIMPLEX-VIRUS
ANTIVIRAL ACTIVITY
INFLUENZA-VIRUS
INDUCED APOPTOSIS
GREEN SYNTHESIS
DRUG-DELIVERY
HEPATITIS-A
IN-VITRO
BIODISTRIBUTION
ANTIBACTERIAL
|
| Ubicación del archivo | |
| Categoría OCDE |
Biotecnología y Microbiología Aplicada
|
| Materias |
Nanopartículas de plata
nanopartículas de cobre
(SARS-CoV-2)
enfermedades virales
actividad antiviral
HERPES-SIMPLEX-VIRUS
ACTIVIDAD ANTIVIRAL
INFLUENZA-VIRUS
APOPTOSIS INDUCIDA
SÍNTESIS VERDE
ENTREGA DE MEDICAMENTOS
HEPATITIS-A
IN-VITRO
BIODISTRIBUCIÓN
ANTIBACTERIAL
|
| Título de la cita (Recomendado-único) |
Silver, copper and copper oxide nanoparticles in the fight against human viruses: progress and perspectives
|
| Página de inicio (Recomendado-único) |
431
|
| Página final (Recomendado-único) |
449
|
| Identificador del recurso (Mandatado-único) |
artículo de revisión
|
| Versión del recurso (Recomendado-único) |
version publicada
|
| Condición de la licencia (Recomendado-repetible) |
0
|
| Derechos de acceso |
metadata
|
| Access Rights |
metadata
|
| Referencia del Financiador (Mandatado si es aplicable-repetible) |
ANID-REDES 180003
FAPESP 2018/08194-2
UFRO DI21-1004
FAPESP 2018/02832-7
CNPq 404815/2018-9
CNPQ 313117/2019-5
ANID-FONDAP 15130015
ANID REDES 180003
ANID FONDAP 15130015
|
| Id de Web of Science |
WOS:000670516800001
|
cienciaabierta.ufro.cl
ciencia.abierta@ufrontera.cl